Literature DB >> 16314532

The class II phosphoinositide 3-kinase C2beta is not essential for epidermal differentiation.

Kazutoshi Harada1, Amy B Truong, Ti Cai, Paul A Khavari.   

Abstract

Phosphoinositide 3-kinases (PI3Ks) regulate an array of cellular processes and are comprised of three classes. Class I PI3Ks include the well-studied agonist-sensitive p110 isoforms; however, the functions of class II and III PI3Ks are less well characterized. Of the three class II PI3Ks, C2alpha and C2beta are widely expressed in many tissues, including the epidermis, while C2gamma is confined to the liver. In contrast to the class I PI3K p110alpha, which is expressed throughout the epidermis, C2beta was found to be localized in suprabasal cells, suggesting a potential role for C2beta in epidermal differentiation. Overexpressing C2beta in epidermal cells in vitro induced differentiation markers. To study a role for C2beta in tissue, we generated transgenic mice overexpressing C2beta in both suprabasal and basal epidermal layers. These mice lacked epidermal abnormalities. Mice deficient in C2beta were then generated by targeted gene deletion. C2beta knockout mice were viable and fertile and displayed normal epidermal growth, differentiation, barrier function, and wound healing. To exclude compensation by C2alpha, RNA interference was then used to knock down both C2alpha and C2beta in epidermal cells simultaneously. Induction of differentiation markers was unaffected in the absence of C2alpha and C2beta. These findings indicate that class II PI3Ks are not essential for epidermal differentiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314532      PMCID: PMC1316983          DOI: 10.1128/MCB.25.24.11122-11130.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

Review 1.  Growth factor regulation of the novel class II phosphoinositide 3-kinases.

Authors:  R A Brown; P R Shepherd
Journal:  Biochem Soc Trans       Date:  2001-08       Impact factor: 5.407

Review 2.  Class I phosphoinositide 3-kinases.

Authors:  Karen E Anderson; Shaun P Jackson
Journal:  Int J Biochem Cell Biol       Date:  2003-07       Impact factor: 5.085

3.  The class II phosphoinositide 3-kinase C2alpha is activated by clathrin and regulates clathrin-mediated membrane trafficking.

Authors:  I Gaidarov; M E Smith; J Domin; J H Keen
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

4.  Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice.

Authors:  R Vassar; M Rosenberg; S Ross; A Tyner; E Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

5.  Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.

Authors:  G J Brunn; J Williams; C Sabers; G Wiederrecht; J C Lawrence; R T Abraham
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

6.  Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor.

Authors:  S Wennström; J Downward
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

7.  Nuclear phosphoinositide 3-kinase C2beta activation during G2/M phase of the cell cycle in HL-60 cells.

Authors:  Dora Visnjić; Josip Curić; Vladiana Crljen; Drago Batinić; Stefano Volinia; Hrvoje Banfić
Journal:  Biochim Biophys Acta       Date:  2003-02-20

8.  Human phosphoinositide 3-kinase C2beta, the role of calcium and the C2 domain in enzyme activity.

Authors:  A Arcaro; S Volinia; M J Zvelebil; R Stein; S J Watton; M J Layton; I Gout; K Ahmadi; J Downward; M D Waterfield
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

9.  Topical treatment with inhibitors of the phosphatidylinositol 3'-kinase/Akt and Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways reduces melanoma development in severe combined immunodeficient mice.

Authors:  Barbara Bedogni; Melony S O'Neill; Scott M Welford; Donna M Bouley; Amato J Giaccia; Nicholas C Denko; Marianne Broome Powell
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

10.  Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration.

Authors:  Tania Maffucci; Frank T Cooke; Fiona M Foster; Colin J Traer; Michael J Fry; Marco Falasca
Journal:  J Cell Biol       Date:  2005-05-31       Impact factor: 10.539

View more
  31 in total

Review 1.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

2.  Phosphatidylinositol-3-kinase C2β and TRIM27 function to positively and negatively regulate IgE receptor activation of mast cells.

Authors:  Shekhar Srivastava; Xinjiang Cai; Zhai Li; Yi Sun; Edward Y Skolnik
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

3.  Requirement for class II phosphoinositide 3-kinase C2alpha in maintenance of glomerular structure and function.

Authors:  David P Harris; Peter Vogel; Marie Wims; Karen Moberg; Juliane Humphries; Kanchan G Jhaver; Christopher M DaCosta; Melanie K Shadoan; Nianhua Xu; Gwenn M Hansen; Sanjeevi Balakrishnan; Jan Domin; David R Powell; Tamas Oravecz
Journal:  Mol Cell Biol       Date:  2010-10-25       Impact factor: 4.272

4.  The class II PI 3-kinase, PI3KC2α, links platelet internal membrane structure to shear-dependent adhesive function.

Authors:  Jessica K Mountford; Claire Petitjean; Harun W Kusuma Putra; Jonathan A McCafferty; Natasha M Setiabakti; Hannah Lee; Lotte L Tønnesen; James D McFadyen; Simone M Schoenwaelder; Anita Eckly; Christian Gachet; Sarah Ellis; Anne K Voss; Ross A Dickins; Justin R Hamilton; Shaun P Jackson
Journal:  Nat Commun       Date:  2015-03-17       Impact factor: 14.919

Review 5.  The transient cortical zone in the adrenal gland: the mystery of the adrenal X-zone.

Authors:  Chen-Che Huang; Yuan Kang
Journal:  J Endocrinol       Date:  2019-02-01       Impact factor: 4.286

Review 6.  PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting.

Authors:  Lauren M Thorpe; Haluk Yuzugullu; Jean J Zhao
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

7.  Phosphatidylinositol 3-kinase class II α-isoform PI3K-C2α is required for transforming growth factor β-induced Smad signaling in endothelial cells.

Authors:  Sho Aki; Kazuaki Yoshioka; Yasuo Okamoto; Noriko Takuwa; Yoh Takuwa
Journal:  J Biol Chem       Date:  2015-01-22       Impact factor: 5.157

8.  PIK3C2B inhibition improves function and prolongs survival in myotubular myopathy animal models.

Authors:  Nesrin Sabha; Jonathan R Volpatti; Hernan Gonorazky; Aaron Reifler; Ann E Davidson; Xingli Li; Nadine M Eltayeb; Claudia Dall'Armi; Gilbert Di Paolo; Susan V Brooks; Ana Buj-Bello; Eva L Feldman; James J Dowling
Journal:  J Clin Invest       Date:  2016-08-22       Impact factor: 14.808

9.  Modeling inducible human tissue neoplasia identifies an extracellular matrix interaction network involved in cancer progression.

Authors:  Jason A Reuter; Susana Ortiz-Urda; Markus Kretz; John Garcia; Florence A Scholl; Anna M G Pasmooij; David Cassarino; Howard Y Chang; Paul A Khavari
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

Review 10.  Phosphoinositides: tiny lipids with giant impact on cell regulation.

Authors:  Tamas Balla
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.